1. Home
  2. RADX
  3. RADX News

Latest RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD (RADX) News on May 9, 2025

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference
RADX

GlobeNewswire

2 days ago

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

RADX

GlobeNewswire

11 days ago

Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis

New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution
RADX

GlobeNewswire

2 months ago

New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution

Positive Signs As Multiple Insiders Buy Radiopharm Theranostics Stock
RADX

Simply Wall St.

2 months ago

Positive Signs As Multiple Insiders Buy Radiopharm Theranostics Stock

New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases
RADX

GlobeNewswire

3 months ago

New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement
RADX

GlobeNewswire

4 months ago

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia
RADX

GlobeNewswire

4 months ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial
RADX

GlobeNewswire

5 months ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Share on Social Networks: